JP2014532760A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532760A5
JP2014532760A5 JP2014541013A JP2014541013A JP2014532760A5 JP 2014532760 A5 JP2014532760 A5 JP 2014532760A5 JP 2014541013 A JP2014541013 A JP 2014541013A JP 2014541013 A JP2014541013 A JP 2014541013A JP 2014532760 A5 JP2014532760 A5 JP 2014532760A5
Authority
JP
Japan
Prior art keywords
compound
agent
acceptable salt
formula
uric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014541013A
Other languages
English (en)
Japanese (ja)
Other versions
JP6008974B2 (ja
JP2014532760A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/059433 external-priority patent/WO2013066353A1/en
Publication of JP2014532760A publication Critical patent/JP2014532760A/ja
Publication of JP2014532760A5 publication Critical patent/JP2014532760A5/ja
Application granted granted Critical
Publication of JP6008974B2 publication Critical patent/JP6008974B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014541013A 2011-11-04 2011-11-04 痛風発赤の治療方法 Expired - Fee Related JP6008974B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/059433 WO2013066353A1 (en) 2011-11-04 2011-11-04 Methods for treating gout flares

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016178714A Division JP6192142B2 (ja) 2016-09-13 2016-09-13 痛風発赤の治療方法

Publications (3)

Publication Number Publication Date
JP2014532760A JP2014532760A (ja) 2014-12-08
JP2014532760A5 true JP2014532760A5 (enExample) 2015-01-22
JP6008974B2 JP6008974B2 (ja) 2016-10-19

Family

ID=48192537

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014541013A Expired - Fee Related JP6008974B2 (ja) 2011-11-04 2011-11-04 痛風発赤の治療方法

Country Status (18)

Country Link
EP (1) EP2775836B8 (enExample)
JP (1) JP6008974B2 (enExample)
KR (1) KR101848121B1 (enExample)
CN (2) CN109045009A (enExample)
AU (1) AU2011380510B2 (enExample)
BR (1) BR112014010729A2 (enExample)
CA (1) CA2859693C (enExample)
CL (1) CL2014001157A1 (enExample)
DK (1) DK2775836T3 (enExample)
EA (1) EA201490928A1 (enExample)
ES (1) ES2698396T3 (enExample)
IL (1) IL232384A (enExample)
MX (1) MX357510B (enExample)
NZ (1) NZ624726A (enExample)
PH (1) PH12014500990A1 (enExample)
PL (1) PL2775836T3 (enExample)
SG (1) SG11201401981TA (enExample)
WO (1) WO2013066353A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080009111A (ko) 2005-04-11 2008-01-24 새비언트 파마수티컬즈 인크. 유레이트 옥시다아제의 변이형 및 이의 용도
JP2012531596A (ja) 2009-06-25 2012-12-10 サヴィエント・ファーマシューティカルズ・インコーポレイテッド Peg化ウリカーゼ療法における血清尿酸をモニタリングすることにより注入反応の危険性および抗体媒介性効果消失を予測するための方法およびキット
US8918181B2 (en) 2010-11-16 2014-12-23 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
AU2013245675B2 (en) * 2012-04-13 2017-02-09 Cymabay Therapeutics, Inc. Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent
CN116637177A (zh) 2016-11-11 2023-08-25 好利恩治疗美国公司 泼尼松和尿酸酶分子的组合疗法及其用途
JP7086980B2 (ja) * 2017-10-26 2022-06-20 大塚製薬株式会社 イノシトールリン酸含有組成物
CN109223707B (zh) * 2018-09-13 2020-12-08 中国药科大学 一种尿酸酶外用凝胶制剂、其制备方法及用途
WO2020160325A1 (en) 2019-01-30 2020-08-06 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
CN114028584B (zh) * 2021-11-18 2023-09-05 辽宁万嘉医药科技有限公司 一种降尿酸的多酚多元环糊精包合物及其制备方法
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers
KR102963966B1 (ko) 2023-12-05 2026-05-11 인제대학교 산학협력단 알코올 스프레이를 활용한 환자 냉각장치

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262118B1 (en) * 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US6624194B1 (en) 1999-06-04 2003-09-23 Metabolex, Inc. Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US8288438B2 (en) * 2005-03-21 2012-10-16 Metabolex, Inc. Methods for avoiding edema in the treatment or prevention of PPARγ-responsive diseases, including cancer
BRPI0819847B1 (pt) * 2007-11-27 2022-01-11 Ardea Biosciences, Inc Compostos e composições
MX2010011603A (es) * 2008-04-30 2011-01-25 Wellstat Therapeutics Corp Compuestos de tetrazol para reducir el acido urico.

Similar Documents

Publication Publication Date Title
JP2012184234A5 (enExample)
JP2013528650A5 (enExample)
JP2017513836A5 (enExample)
US10537570B2 (en) Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
JP2013528655A5 (enExample)
EP2775836B1 (en) Methods for treating gout flares
JP5978216B2 (ja) テオフィリンとフェブキソスタットの併用療法のための方法
WO2014065275A1 (ja) 腫瘍融解症候群の治療薬及び予防薬
TW201908298A (zh) 胺烷基苯並硫氮呯衍生物之用途
JP2011507896A5 (enExample)
US20180117042A1 (en) Methods for treating respiratory syncytial virus infection
JP2014505107A5 (enExample)
US20210260025A1 (en) Capsid assembly modulator dosing regimen
JP2015535247A5 (enExample)
WO2019046287A1 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEPATITIS B
US10137112B2 (en) Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent
EP3035934A2 (en) Compositions and therapeutic methods for accelerated plaque regression
JP2019507791A5 (enExample)
WO2021262799A1 (en) Anti-viral compounds and methods of using same
JP2013087119A5 (enExample)
RU2014115733A (ru) Новая соль и медицинское применение
JP6202633B2 (ja) ハロフェナートまたはハロフェン酸および第2の尿酸低下薬を用いる痛風に罹っている患者の高尿酸血症の治療方法
JP2014532759A5 (enExample)
JP2015512948A (ja) ハロフェナートまたはハロフェン酸および抗炎症剤を用いる痛風に罹っている患者の高尿酸血症の治療方法
KR101848122B1 (ko) 환자 부분모집단에서의 통풍 치료 방법